To launch a TRT telehealth clinic in 90 days, you need to simultaneously file for entity formation, initiate DEA Schedule III registration, apply for state telehealth licenses, negotiate compounding pharmacy agreements, and select a HIPAA-compliant EHR with EPCS capability. The DEA registration process (30–45 days) and state licensing timelines are your critical path. Founders who start paperwork in week one while evaluating technology in weeks two and three consistently hit the 90-day mark. Startup costs range from $15,000 to $50,000 depending on multi-state scope and marketing spend. Expect to reach cash-flow break-even around months 4–7 with consistent patient acquisition.
Why 90 Days Is the Right Timeline
Sixty days is too short. The DEA registration process alone averages 30–45 days, and state medical licensing — even for established physicians adding a telehealth modality — adds weeks of processing time in most jurisdictions. Trying to launch in 60 days means accepting that you may have your technology ready but no legal authority to prescribe testosterone when you flip the switch.
Six months is too long for a different reason: it bleeds startup capital without generating revenue and gives you too much runway to second-guess decisions that should be made and committed to in week two. Founder paralysis around EHR selection, pharmacy partnerships, and pricing structure is the most common cause of extended timelines. The 90-day constraint forces decisive action.
Ninety days works because it maps cleanly to three parallel tracks that each take roughly 30 days to complete: the legal and regulatory track (entity, DEA, licensing), the operational track (technology, protocols, pharmacy), and the go-to-market track (website, funnel, content, advertising). Running all three simultaneously rather than sequentially is what separates a 90-day launch from a 6-month struggle. For a broader strategic overview of the business model before diving into the checklist, see the guide to launching a profitable TRT/HRT telehealth practice.
Projected U.S. TRT market size by 2027. The telehealth channel captures an increasing share as patients seek convenient, affordable access to hormone optimization outside traditional endocrinology and urology practices.
The TRT telehealth market rewards speed. A founder who launches in month three has a meaningful first-mover advantage in their target geography over a competitor still negotiating their EHR contract in month four. Every week of delay is roughly $3,000–$6,000 in foregone monthly recurring revenue that a 20-patient panel would have generated. The 90-day discipline is not arbitrary — it is financially rational.
Phase 1 — Foundation (Days 1–30)
Phase one is entirely about creating the legal and operational infrastructure that permits you to prescribe controlled substances and operate as a healthcare entity. Nothing in phase two or three is possible without it. The work is unglamorous — filing paperwork, executing agreements, waiting for government agencies — but every day of delay here cascades forward.
Entity Formation and Legal Structure
Most TRT telehealth founders structure their business as a professional medical corporation (PC) or professional limited liability company (PLLC), depending on state law. The clinical entity must be owned by a licensed physician in most states — corporate practice of medicine (CPOM) doctrine prohibits lay ownership of medical practices in California, New York, Texas, and many others. A management services organization (MSO) structure is commonly used to allow non-physician investors or co-founders to participate in the business economics while keeping the PC fully physician-owned.
Work with a healthcare attorney who specializes in telehealth from the first week. Do not use a general business attorney. The intersection of CPOM doctrine, state telehealth prescribing rules for controlled substances, and the Ryan Haight Act requirements is complex enough to create material legal exposure if structured incorrectly. Attorney fees at this stage ($2,000–$5,000) are the best money you will spend in the entire 90 days.
Key decisions in entity formation: state of incorporation versus state of operations, whether you are using an MSO structure, how telehealth prescribing across multiple states is handled (each state may require a separate PC entity or a formal interstate compact enrollment), and how intellectual property such as proprietary protocols is held.
DEA Registration and State Licensing
Testosterone cypionate and testosterone enanthate — the two injectable forms prescribed by most TRT clinics — are classified as Schedule III controlled substances under the Controlled Substances Act. Every prescriber in your clinic must hold an active DEA Controlled Substance Registration at a registered principal office address. The DEA online registration application is straightforward, but the approval timeline averages 30–45 calendar days. Submit on day one.
The Ryan Haight Online Pharmacy Consumer Protection Act (2008) imposes an in-person evaluation requirement before prescribing Schedule III controlled substances via telemedicine. DEA telemedicine rules have evolved significantly following the COVID-19 public health emergency, and new proposed rules are pending as of early 2026. Consult DEA-specialist healthcare counsel for the current in-person exemption landscape in your target states. Some qualifying conditions and state frameworks may permit remote-first prescribing; the rules are genuinely complex and enforcement is active.
State licensing is the other major day-one workstream. Physicians practicing telemedicine must hold a medical license in every state where patients are physically located when the consultation occurs. The Interstate Medical Licensure Compact (IMLC) dramatically accelerates multi-state licensure for eligible physicians — IMLC can reduce a 3–6 month state-by-state process to 30–60 days for most participating states. Enroll in IMLC immediately if you are targeting more than two states at launch.
Malpractice Insurance
Obtain professional liability (malpractice) insurance before seeing a single patient. For a TRT telehealth practice, expect annual premiums in the range of $3,000–$8,000 for a solo prescriber. Carriers with significant telehealth and hormone therapy books include CUNA Mutual (ProAssurance), The Doctors Company, and NORCAL. Ensure your policy explicitly covers telehealth-delivered care, controlled substance prescribing, and the states in which you are licensed.
An occurrence-based policy provides coverage for any incident that occurred during the policy period, regardless of when a claim is filed. A claims-made policy only covers claims filed while the policy is active. Occurrence-based is generally preferred for new practices but carries a higher premium. Discuss with your broker.
Compounding Pharmacy Partnerships
Most TRT telehealth clinics work with one or more compounding pharmacies to fulfill testosterone injections, anastrozole, HCG, enclomiphene, and ancillary medications. The pharmacy landscape divides into two FDA categories: 503A compounding pharmacies, which prepare prescriptions for individual patients on a per-prescription basis, and 503B outsourcing facilities, which compound in bulk for clinics and hospitals without individual patient prescriptions. 503B facilities are subject to more rigorous FDA oversight and cGMP standards, making them preferable for clinics with volume above a few hundred prescriptions per month.
Establish at least two pharmacy partnerships. Single-pharmacy dependency is an operational risk — FDA warning letters, supply chain issues, and quality holds have disrupted single-pharmacy-dependent clinics repeatedly. Geographic coverage matters as well; some states restrict which compounding pharmacies can ship to patients, and having a backup in a different jurisdiction protects continuity.
Before executing a contract with any compounding pharmacy, verify PCAB accreditation (or equivalent quality certification), confirm their DEA Schedule III registration is active, review their quality assurance documentation, and execute a Business Associate Agreement (BAA) covering PHI shared for fulfillment. The BAA is not optional — transmitting patient name, address, diagnosis, and prescription information to the pharmacy creates a covered entity/business associate relationship under HIPAA.
Phase 2 — Build (Days 31–60)
By day 31 your DEA application is pending (expected approval by day 40–45), state licenses are in queue, and pharmacy agreements are executed. Phase two is when you build the operational infrastructure that will run the clinic. The goal is to have every system fully configured, tested, and credentialed by day 60 so that phase three is execution, not setup.
Technology Platform Setup
The technology stack decision is the highest-leverage choice in phase two. TRT telehealth requires a remarkably specific combination of capabilities: HIPAA-compliant EHR, DEA-compliant EPCS for Schedule III prescriptions, telehealth video (synchronous or asynchronous), automated lab result routing, subscription billing, and a patient-facing portal. Most early-stage founders underestimate the operational complexity of stitching together five or six point solutions from different vendors — each with its own BAA, integration requirements, and support relationship.
Purpose-built specialty telehealth platforms designed for hormone optimization and TRT practices integrate these capabilities natively. The evaluation criteria that matter most for a TRT practice are: Does the platform support EPCS for Schedule III controlled substances out of the box? Can it route lab results directly to the patient portal and flag out-of-range values for physician review? Does it support subscription billing with the ability to pause and reactivate memberships? And is the BAA readily available from the vendor without a prolonged procurement process? For a detailed vendor comparison, see the TRT telehealth software buyer's guide for 2026.
Configuration during phase two includes: building your intake questionnaire and medical history forms, configuring the telehealth video consultation workflow, setting up prescription templates for testosterone cypionate, anastrozole, and ancillaries, integrating your lab vendor accounts, and configuring payment processing for your subscription model.
Protocol Development
Your clinical protocols are the medical and operational foundation of the practice. For TRT, the core protocol stack includes: initial evaluation criteria (inclusion and exclusion criteria, required baseline labs), starting dose and formulation guidelines (testosterone cypionate 100–200mg/week injection, topical alternatives), follow-up lab schedule (week 6, week 12, then semi-annual), monitoring parameters (total testosterone, free testosterone, hematocrit, PSA, estradiol), estrogen management protocol (anastrozole use criteria), and off-cycle or fertility protocol (HCG or enclomiphene pathways).
Protocol development must be led by the prescribing physician and reviewed by a healthcare attorney for compliance with state medical board standards. Written protocols also serve as evidence of standard-of-care adherence in any malpractice or regulatory review. Protocols should be versioned, dated, and signed.
Lab Vendor Integration
TRT requires regular bloodwork: comprehensive metabolic panel, complete blood count, lipid panel, total and free testosterone, estradiol, PSA (for men over 40), LH, FSH, and SHBG at baseline. Most TRT telehealth clinics use LabCorp, Quest Diagnostics, or specialty labs like Ulta Lab Tests that allow patient-initiated ordering without a physician visit for baseline testing. Integration with your EHR allows lab orders to be generated within the provider workflow and results to route automatically back to the patient record.
Negotiate a direct billing account with your primary lab vendor during phase two. Account setup can take 2–3 weeks. Lab costs are typically passed through to patients, either embedded in membership pricing or billed separately. Know your per-panel cost and model your pricing accordingly.
HIPAA-Compliant Payment Processing
Credit card processing for a TRT practice involves PHI because the billing record contains patient identity, service date, and diagnosis codes. Your payment processor must execute a BAA if they handle PHI in the course of processing. Not all payment processors offer BAAs — Stripe, PaymentSpring, and specialized healthcare billing platforms do. Standard Stripe for non-healthcare businesses does not include a BAA; Stripe's healthcare offering does. Verify BAA availability with any payment vendor before onboarding.
TRT practices almost universally use a subscription billing model: a fixed monthly membership fee that includes consultations, physician review of labs, and shipping (with pharmacy costs either bundled or billed separately). Subscription billing requires a system that handles failed payment retries, pause and cancellation requests, prorated billing for mid-cycle changes, and refund processing. Configure all of these scenarios during phase two so they do not become operational crises in phase three. For guidance on structuring your membership tiers and maximizing revenue per patient, see the analysis of TRT pricing strategy and patient lifetime value.
Website and Patient Acquisition Funnel
Build the patient-facing website and intake funnel during phase two so you have time to test and iterate before launch. The TRT telehealth conversion funnel typically follows this structure: paid ad or organic search traffic lands on a condition-specific landing page, patient completes a short online symptom assessment, assessment is followed by a pricing and membership explanation page, patient schedules a consultation or initiates checkout, lab order is generated, and physician reviews labs and consultation before initiating treatment.
Your website needs a minimum of four conversion-ready pages: a homepage that communicates the value proposition clearly, a TRT-specific landing page optimized for search intent, an about/our-physicians page that builds prescriber credibility, and a pricing/how-it-works page that removes objections. All forms collecting patient health information must be HIPAA-compliant — a standard web contact form is not sufficient. Use a form solution with a BAA or route inquiries through your EHR patient portal.
Phase 3 — Launch (Days 61–90)
Phase three is not the time to be finalizing systems. It is the time to be running patients through a complete, tested workflow with real humans while simultaneously activating marketing. Most founders make the mistake of treating the first day of marketing as their launch. The correct approach is a soft launch with 10–20 patients beginning around day 65, followed by full marketing activation around day 80 once you have evidence the end-to-end workflow operates without friction.
Soft Launch and Workflow Testing
Your soft launch cohort — friends, referrals, early waitlist signups — gives you the opportunity to run a complete patient journey before scaling. Walk 10–20 patients through: intake form submission, consultation scheduling, physician video consultation, lab order generation, lab result routing to portal, treatment plan communication, prescription send to pharmacy, and shipping confirmation. Document every friction point. At this volume, problems are fixable in hours. At 100+ patients, they become operational crises.
Specific things to verify during soft launch: that EPCS-signed testosterone prescriptions route correctly to your compounding pharmacy's system, that lab result PDFs render correctly in the patient portal, that subscription billing fires correctly on day 30, that the automated follow-up sequence (lab reminder at week 5, check-in at week 8) executes as designed, and that your team (or you, solo) can handle the consultation volume without bottlenecking. If a consultation takes 25 minutes instead of the planned 15, your capacity is 40% lower than projected — you need to know this before you spend $5,000 on paid ads.
Compliance Audit
Between day 70 and day 80, conduct a formal compliance audit before full marketing activation. The audit should cover four areas: HIPAA technical safeguards (encryption at rest and in transit, access controls, audit logging), BAA completeness (verify you have executed BAAs with every vendor that touches PHI), prescribing compliance (verify every prescription written during soft launch has appropriate documentation, consent, and a valid DEA-compliant prescriber signature), and state telehealth compliance (confirm your in-person or qualifying evaluation documentation for each Schedule III prescription is complete for each state where patients are located). The multi-state TRT prescribing compliance guide covers the state-specific documentation requirements in detail.
A compliance audit at this stage is not a legal luxury — it is risk management. A single prescribing compliance gap discovered by a state medical board at 50 patients is dramatically less costly to remediate than the same gap discovered at 500 patients.
Marketing Activation
Full marketing activation begins around day 80, after soft launch workflow issues are resolved and compliance is confirmed. TRT telehealth marketing operates across three channels that should be activated simultaneously: paid search (Google Ads targeting high-intent TRT keywords), content/SEO (blog articles and landing pages targeting informational TRT queries — this channel is slow but compounds over 12–24 months), and referral (physician referral networks, men's health communities, fitness influencer partnerships).
Paid search for TRT keywords is competitive and subject to Google's healthcare advertising policies, which require certification for certain categories. Budget $2,000–$5,000/month to test paid acquisition in the first 90 days. Track cost per acquisition (CPA) obsessively — a CPA above $200 for a $150/month membership is financially unsustainable. Adjust bids, landing page copy, and ad creatives until CPA is below $150 before scaling spend.
90-Day Timeline Visualization
Startup Budget Breakdown
Total startup costs vary significantly based on founder profile, target state count, and marketing aggression. A physician founder with an existing DEA registration launching in one state and building the funnel themselves can launch for under $15,000. A two-physician partnership targeting five states with an agency-built website and $5,000/month paid acquisition budget will spend closer to $50,000 before reaching month-3 revenue. The table below reflects the realistic range.
| Budget Category | Low Estimate | High Estimate | Notes |
|---|---|---|---|
| Legal & Entity Formation | $2,000 | $8,000 | State filing fees + healthcare attorney. MSO structure adds cost. |
| DEA Registration Fees | $888 | $2,664 | $888/prescriber. Multi-physician practice multiplies accordingly. |
| State Medical Licensing | $300 | $2,500 | $150–$500/state. IMLC fee + individual state fees. |
| Malpractice Insurance (Year 1) | $3,000 | $8,000 | Per prescriber. Telehealth + controlled substance coverage required. |
| Technology Platform (Year 1) | $3,000 | $12,000 | EHR + EPCS + telehealth + patient portal. All-in-one vs. point solutions. |
| Website & Funnel Build | $500 | $8,000 | DIY on no-code platform vs. agency-built custom site. |
| Lab Vendor Setup | $0 | $500 | Direct billing account is typically free. Integration setup may cost. |
| Initial Marketing & Paid Ads | $2,000 | $10,000 | First 90 days Google Ads + content. Scales with budget after proof. |
| Working Capital Buffer | $2,000 | $5,000 | Cover payroll, subscription renewals, and unexpected delays. |
| Total Estimated Range | $13,688 | $56,664 | Lean solo launch vs. multi-physician multi-state with agency support. |
These estimates assume the prescribing physician has an active medical license in at least one state and an active DEA registration or can obtain one. If DEA registration does not exist (e.g., physician previously worked only in hospital settings without personal DEA), add $888 and 30–45 days to your critical path. Also budget for a healthcare attorney retainer at $500–$1,500/month for ongoing compliance questions — this is not a one-time cost.
Month-by-Month Revenue Projections
The revenue model below assumes a $179/month membership (inclusive of consultations and physician oversight, with pharmacy costs billed separately through the compounding pharmacy), a 4% monthly churn rate, and a cost per patient acquisition that begins at $180 and improves to $120 by month 9 as organic/referral channels mature. These are representative figures — your economics will differ based on pricing, marketing channel mix, and specialty mix.
| Month | New Patients | Active Patients | MRR | Est. Revenue | Status |
|---|---|---|---|---|---|
| Month 1 | 8 | 8 | $1,432 | $716 | Pre-revenue / soft launch |
| Month 2 | 15 | 22 | $3,938 | $3,938 | Growth |
| Month 3 | 20 | 41 | $7,339 | $7,339 | Growth |
| Month 4 | 25 | 64 | $11,456 | $11,456 | Approaching break-even |
| Month 5 | 30 | 91 | $16,289 | $16,289 | Break-even (lean model) |
| Month 6 | 35 | 122 | $21,838 | $21,838 | Profitable |
| Month 7 | 40 | 157 | $28,103 | $28,103 | Scale phase |
| Month 8 | 45 | 196 | $35,084 | $35,084 | Scale phase |
| Month 9 | 50 | 238 | $42,602 | $42,602 | Scale phase |
| Month 10 | 55 | 284 | $50,836 | $50,836 | Scale phase |
| Month 11 | 60 | 333 | $59,607 | $59,607 | Scale phase |
| Month 12 | 65 | 385 | $68,915 | $68,915 | $825K ARR run rate |
Month 1 revenue is partial because soft launch patients start mid-month. Month 5 break-even assumes $15,000/month in overhead (technology, marketing, and physician time cost). Clinics with hired NPs or PAs carrying physician salary overhead will break even between months 6 and 8 depending on salary structure. The 4% monthly churn rate (48% annual) is typical for direct-to-consumer TRT programs — patients on treatment tend to stay because stopping therapy requires a managed tapering process.
Three variables move the revenue curve most significantly: average revenue per patient (ARPU) — adding add-on protocols like peptide therapy or DHEA at $50–$75/month can raise ARPU by 30–40%; patient acquisition cost (PAC) — improving from $180 to $120 through referral and organic channels improves payback period by nearly a full month; and monthly churn — reducing churn from 4% to 2.5% by implementing proactive check-in automation adds 15–20% to 12-month LTV.
Common Launch Mistakes and How to Avoid Them
Starting Technology Selection Too Late
Many founders delay EHR and platform selection until after DEA approval, treating technology as a phase-two-only task. This wastes 4–6 weeks where setup, configuration, and testing could have been completed in parallel.
Single Pharmacy Dependency
Launching with only one compounding pharmacy means a single FDA warning letter, quality hold, or shipping disruption stops your ability to fulfill prescriptions entirely. This has disrupted multiple TRT clinics that scaled quickly on a single-pharmacy model.
Missing BAAs with All PHI Vendors
Many founders execute the EHR BAA and overlook the payment processor, SMS platform, email marketing tool, and even Google Analytics configurations that may transmit PHI. An OCR audit will find every gap.
Launching Paid Ads Before Workflow Is Tested
Founders eager to generate revenue often activate Google Ads the day they receive DEA registration, before the intake-to-treatment workflow has been tested. The first 50 paid patients experience a broken journey, generating refund requests and negative word-of-mouth.
Ignoring State-Specific Telehealth Prescribing Rules
The federal Ryan Haight Act interacts differently with each state's telehealth practice act. Some states require specific consent language; others have enacted their own controlled substance telehealth prescribing restrictions. Treating all 50 states as uniform is a compliance error.
Under-Investing in Patient Retention Systems
Founders obsess over acquisition and neglect the retention infrastructure: automated lab reminder sequences, check-in messages at week 8, proactive outreach for missed refills. At 4% monthly churn, you lose nearly half your patient base annually without retention effort.
Frequently Asked Questions
How long does it actually take to launch a TRT telehealth clinic?
A focused founder can launch a TRT telehealth clinic in 90 days if they move through legal formation, DEA registration, state medical licensing, compounding pharmacy contracting, and technology setup in sequential parallel tracks. The most common delays are DEA registration (30–45 days) and state telehealth licensing (variable by state). Founders who line up their technology platform and pharmacy partner in weeks 1–4 while DEA paperwork processes avoid the bottlenecks that extend timelines to 6 months.
What DEA registration does a TRT clinic need?
TRT clinics prescribing testosterone require a DEA Controlled Substance Registration because testosterone is a Schedule III controlled substance. Every prescribing physician must hold an active DEA registration at a registered address. The Ryan Haight Online Pharmacy Consumer Protection Act requires at least one in-person evaluation before prescribing Schedule III controlled substances via telehealth, though DEA telemedicine rules have evolved significantly since 2020 — consult DEA counsel for current guidance on qualifying telehealth exemptions. Registration fees are $888 per practitioner and applications are processed through the DEA Diversion Control Division online portal.
What does it cost to launch a TRT telehealth clinic?
Total startup costs for a TRT telehealth clinic range from $15,000 to $50,000 depending on scope. The primary cost categories are: legal and entity formation ($2,000–$8,000), DEA and state licensing fees ($1,500–$4,000), malpractice insurance first-year premium ($3,000–$8,000), technology platform setup ($3,000–$12,000 first year), lab vendor setup ($0–$500), website and marketing ($2,500–$18,000), and working capital buffer ($2,000–$5,000). Solo-founder lean launches with an existing medical license come in at the low end; multi-state partnerships with hired NPs and aggressive paid acquisition come in at the high end.
Do TRT telehealth clinics need a compounding pharmacy partnership?
Most TRT telehealth clinics partner with one or more 503A or 503B compounding pharmacies to fulfill testosterone cypionate injections and ancillary medications like anastrozole, HCG, and enclomiphene. FDA-approved commercial testosterone products are available through standard retail pharmacies, but compounded formulations often offer cost advantages and dosing flexibility. Working with a 503B outsourcing facility is advisable for clinics with significant monthly volume. You must execute a Business Associate Agreement (BAA) with any pharmacy that handles patient PHI. Vet each compounding pharmacy for PCAB accreditation or equivalent quality certifications and verify their active DEA registration.
What technology stack does a TRT telehealth clinic need?
A TRT telehealth clinic needs: a HIPAA-compliant EHR or practice management platform; a DEA-compliant Electronic Prescribing for Controlled Substances (EPCS) module; a telehealth video platform with BAA; a HIPAA-compliant payment processor for subscription billing; a patient portal for lab result review, intake forms, and secure messaging; lab integration APIs for automated result routing; and a compliant CRM or patient engagement system for follow-up and retention. Purpose-built specialty telehealth platforms bundle these capabilities natively, avoiding the fragmented vendor relationships and integration overhead of assembling point solutions.
What revenue should a new TRT clinic expect in the first 12 months?
A new TRT telehealth clinic can realistically reach 50–100 active patients by month 6 and 150–250 active patients by month 12 with consistent marketing spend. At $150–$200/month per patient (membership model inclusive of consultations), a 100-patient clinic generates $15,000–$20,000 in monthly recurring revenue. A 250-patient clinic generates $37,500–$50,000 MRR. Most clinics reach cash-flow break-even around months 4–7 depending on overhead structure. TRT programs have naturally low monthly churn (3–6%) because patients on active testosterone therapy require ongoing prescriptions — this structural retention advantage makes the subscription economics exceptionally durable once established.
Launch Your TRT Clinic on LUKE Health
LUKE Health is purpose-built for specialty telehealth practices prescribing hormones and controlled substances. Native EPCS for Schedule III, automated lab routing, HIPAA-compliant subscription billing, and compounding pharmacy integrations — everything in this playbook, in one platform.